Skip NavigationSkip to Content

Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies

  1. Author:
    Golding, H.
    Ouyang, J.
    Zaitseva, M.
    Broder, C. C.
    Dimitrov, D. S.
    Lapham, C.
  2. Author Address

    Golding H US FDA, Div Viral Prod, CBER Bldg 29B,Room 4NN04,8800 Rockville Pike Bethesda, MD 20892 USA US FDA, Div Viral Prod, CBER Bethesda, MD 20892 USA NCI, Sect Membrane Struct & Funct, FCRDC, NIH Frederick, MD 21702 USA Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol Bethesda, MD 20814 USA
    1. Year: 1999
  1. Journal: Aids Research and Human Retroviruses
    1. 15
    2. 2
    3. Pages: 149-159
  2. Type of Article: Article
  1. Abstract:

    CD4-specific monoclonal antibodies (CG1, CG7, and CG8), which bind,vith a 5- to 10-fold higher avidity to preformed CD4-gp120 complexes than to CD4, were previously shown to recognize newly identified conformational epitopes in the D1-CDR3 region of CD4, In the current study, these and other complex-enhanced MAbs were tested in three separate assays of HIV-1 coreceptor (CXCR4/CCR5) recruitment. In these assays, the CD4-specific MAbs CG1, -7, and -8 stabilized the association of coreceptor, gp120, and CD4 in trimolecular complexes. In contrast, the gp120-specific, complex-enhanced MAbs 48d and 17b were inhibitory. These data suggest that conformational changes in the CDR3 region of CD4-D1, induced by gp120 binding, may be involved in coreceptor association and thus play a positive role in the HIV-1 cell fusion process. [References: 30]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel